JP2018516266A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018516266A5 JP2018516266A5 JP2017561947A JP2017561947A JP2018516266A5 JP 2018516266 A5 JP2018516266 A5 JP 2018516266A5 JP 2017561947 A JP2017561947 A JP 2017561947A JP 2017561947 A JP2017561947 A JP 2017561947A JP 2018516266 A5 JP2018516266 A5 JP 2018516266A5
- Authority
- JP
- Japan
- Prior art keywords
- celecoxib
- pain
- composition
- pharmaceutical composition
- liquid pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 34
- 239000007788 liquid Substances 0.000 claims 24
- 239000008194 pharmaceutical composition Substances 0.000 claims 22
- RZEKVGVHFLEQIL-UHFFFAOYSA-N celecoxib Chemical compound C1=CC(C)=CC=C1C1=CC(C(F)(F)F)=NN1C1=CC=C(S(N)(=O)=O)C=C1 RZEKVGVHFLEQIL-UHFFFAOYSA-N 0.000 claims 20
- 229960000590 celecoxib Drugs 0.000 claims 20
- 208000002193 Pain Diseases 0.000 claims 18
- 239000002775 capsule Substances 0.000 claims 8
- 229940029106 celecoxib 400 mg Drugs 0.000 claims 8
- 239000002904 solvent Substances 0.000 claims 7
- 238000000034 method Methods 0.000 claims 6
- 125000005456 glyceride group Chemical group 0.000 claims 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims 4
- 239000002798 polar solvent Substances 0.000 claims 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical group CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 3
- 239000012530 fluid Substances 0.000 claims 3
- 230000002496 gastric effect Effects 0.000 claims 3
- 208000004296 neuralgia Diseases 0.000 claims 3
- 238000001556 precipitation Methods 0.000 claims 3
- 238000003756 stirring Methods 0.000 claims 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 2
- 239000002202 Polyethylene glycol Substances 0.000 claims 2
- 239000000839 emulsion Substances 0.000 claims 2
- 235000020937 fasting conditions Nutrition 0.000 claims 2
- 208000021722 neuropathic pain Diseases 0.000 claims 2
- 239000008203 oral pharmaceutical composition Substances 0.000 claims 2
- 229920001223 polyethylene glycol Polymers 0.000 claims 2
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 claims 2
- 239000000243 solution Substances 0.000 claims 2
- 239000000725 suspension Substances 0.000 claims 2
- 229920002554 vinyl polymer Polymers 0.000 claims 2
- 206010049589 Afterbirth pain Diseases 0.000 claims 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 claims 1
- 208000008035 Back Pain Diseases 0.000 claims 1
- 208000006561 Cluster Headache Diseases 0.000 claims 1
- 229920000858 Cyclodextrin Polymers 0.000 claims 1
- 206010013935 Dysmenorrhoea Diseases 0.000 claims 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 claims 1
- 206010065390 Inflammatory pain Diseases 0.000 claims 1
- 208000003456 Juvenile Arthritis Diseases 0.000 claims 1
- 206010059176 Juvenile idiopathic arthritis Diseases 0.000 claims 1
- 208000007914 Labor Pain Diseases 0.000 claims 1
- 208000035945 Labour pain Diseases 0.000 claims 1
- 208000008930 Low Back Pain Diseases 0.000 claims 1
- 208000019695 Migraine disease Diseases 0.000 claims 1
- 206010068319 Oropharyngeal pain Diseases 0.000 claims 1
- 208000004983 Phantom Limb Diseases 0.000 claims 1
- 206010056238 Phantom pain Diseases 0.000 claims 1
- 201000007100 Pharyngitis Diseases 0.000 claims 1
- 208000004550 Postoperative Pain Diseases 0.000 claims 1
- 206010061363 Skeletal injury Diseases 0.000 claims 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims 1
- 206010042496 Sunburn Diseases 0.000 claims 1
- -1 acetate-polyethylene Chemical group 0.000 claims 1
- 208000005298 acute pain Diseases 0.000 claims 1
- 150000001298 alcohols Chemical class 0.000 claims 1
- 230000002917 arthritic effect Effects 0.000 claims 1
- 229920001400 block copolymer Polymers 0.000 claims 1
- 229940090755 celecoxib 400 mg oral capsule Drugs 0.000 claims 1
- 239000001913 cellulose Substances 0.000 claims 1
- 229920002678 cellulose Polymers 0.000 claims 1
- 208000019069 chronic childhood arthritis Diseases 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 208000018912 cluster headache syndrome Diseases 0.000 claims 1
- 201000003146 cystitis Diseases 0.000 claims 1
- 235000011187 glycerol Nutrition 0.000 claims 1
- 229940087068 glyceryl caprylate Drugs 0.000 claims 1
- 229920000578 graft copolymer Polymers 0.000 claims 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 201000002215 juvenile rheumatoid arthritis Diseases 0.000 claims 1
- 229960003511 macrogol Drugs 0.000 claims 1
- 238000005259 measurement Methods 0.000 claims 1
- 206010027599 migraine Diseases 0.000 claims 1
- 239000003921 oil Substances 0.000 claims 1
- 230000003349 osteoarthritic effect Effects 0.000 claims 1
- 230000035699 permeability Effects 0.000 claims 1
- 229920001983 poloxamer Polymers 0.000 claims 1
- 239000008389 polyethoxylated castor oil Substances 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 claims 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims 1
- 150000005846 sugar alcohols Polymers 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 claims 1
- 208000004371 toothache Diseases 0.000 claims 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical group CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 claims 1
- 208000009935 visceral pain Diseases 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2682CH2015 | 2015-05-28 | ||
| IN2682/CHE/2015 | 2015-05-28 | ||
| IN6614/CHE/2015 | 2015-12-10 | ||
| IN6614CH2015 | 2015-12-10 | ||
| PCT/US2016/034844 WO2016191744A1 (en) | 2015-05-28 | 2016-05-27 | Oral composition of celecoxib for treatment of pain |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018516266A JP2018516266A (ja) | 2018-06-21 |
| JP2018516266A5 true JP2018516266A5 (enExample) | 2018-08-30 |
| JP6605047B2 JP6605047B2 (ja) | 2019-11-13 |
Family
ID=56137539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017561947A Active JP6605047B2 (ja) | 2015-05-28 | 2016-05-27 | 疼痛治療のためのセレコキシブの経口用組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (7) | US9572819B2 (enExample) |
| EP (1) | EP3302429A1 (enExample) |
| JP (1) | JP6605047B2 (enExample) |
| KR (1) | KR101994129B1 (enExample) |
| CN (3) | CN117547528A (enExample) |
| AU (2) | AU2016267685A1 (enExample) |
| CA (1) | CA2987272C (enExample) |
| EA (1) | EA038013B1 (enExample) |
| MX (1) | MX384044B (enExample) |
| NZ (1) | NZ737561A (enExample) |
| RU (1) | RU2708254C2 (enExample) |
| WO (1) | WO2016191744A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117547528A (zh) * | 2015-05-28 | 2024-02-13 | 瑞迪博士实验室有限公司 | 用于治疗疼痛的塞来昔布口服组合物 |
| BR112018074486A2 (pt) | 2016-05-27 | 2019-05-28 | Dr Reddy´S Laboratories Ltd | composição oral de celecoxib para tratamento da dor |
| US11108393B2 (en) | 2018-01-05 | 2021-08-31 | Darfon Electronics Corp. | Optical keyswitch triggered by support mechanism having at least one rotatable frame enable a protrusion to move along with a key cap |
| US11770123B2 (en) | 2018-01-05 | 2023-09-26 | Darfon Electronics Corp. | Optical keyswitch comprising a keycap having a light transmission area and a keycap projection area projected on a circuit board |
| WO2022144590A1 (en) | 2020-12-28 | 2022-07-07 | Dr. Reddy's Laboratories Ltd. | Celecoxib for treating pain |
| US11735379B2 (en) | 2021-04-07 | 2023-08-22 | Darfon Electronics Corp. | Keyswitch assembly |
| US11721500B2 (en) | 2021-04-07 | 2023-08-08 | Darfon Electronics Corp. | Keyswitch assembly and support mechanism thereof |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2111065T5 (es) | 1991-04-16 | 2005-06-16 | Nippon Shinyaku Company, Limited | Procedimiento para producir una dispersion solida. |
| NZ276885A (en) | 1993-11-30 | 1999-08-30 | Searle & Co | Substituted pyrazolyl-benzenesulphonamide derivatives, preparation and pharmaceutical compositions thereof |
| US5466823A (en) | 1993-11-30 | 1995-11-14 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides |
| GB9405304D0 (en) | 1994-03-16 | 1994-04-27 | Scherer Ltd R P | Delivery systems for hydrophobic drugs |
| US5993858A (en) | 1996-06-14 | 1999-11-30 | Port Systems L.L.C. | Method and formulation for increasing the bioavailability of poorly water-soluble drugs |
| ES2174462T3 (es) | 1997-07-29 | 2002-11-01 | Upjohn Co | Formulacion autoestimulante para compuestos lipofilos. |
| EP2127642A3 (en) | 1998-08-13 | 2010-02-24 | Cima Labs, Inc. | Microemulsions as solid dosage forms for oral administration |
| SA99191255B1 (ar) | 1998-11-30 | 2006-11-25 | جي دي سيرل اند كو | مركبات سيليكوكسيب celecoxib |
| CN1236813C (zh) | 1998-12-11 | 2006-01-18 | 药品处理公司 | 水难溶性药物的自乳化组合物 |
| US6761903B2 (en) | 1999-06-30 | 2004-07-13 | Lipocine, Inc. | Clear oil-containing pharmaceutical compositions containing a therapeutic agent |
| US6294192B1 (en) | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
| US7374779B2 (en) | 1999-02-26 | 2008-05-20 | Lipocine, Inc. | Pharmaceutical formulations and systems for improved absorption and multistage release of active agents |
| US6267985B1 (en) | 1999-06-30 | 2001-07-31 | Lipocine Inc. | Clear oil-containing pharmaceutical compositions |
| US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| US6383471B1 (en) * | 1999-04-06 | 2002-05-07 | Lipocine, Inc. | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
| US6057289A (en) | 1999-04-30 | 2000-05-02 | Pharmasolutions, Inc. | Pharmaceutical composition comprising cyclosporin in association with a carrier in a self-emulsifying drug delivery system |
| US6720001B2 (en) | 1999-10-18 | 2004-04-13 | Lipocine, Inc. | Emulsion compositions for polyfunctional active ingredients |
| PL203262B1 (pl) * | 1999-12-08 | 2009-09-30 | Pharmacia Corp | Substancja lecznicza celekoksyb, jej zastosowanie i sposób jej wytwarzania, kompozyt celekoksyb-inhibitor krystalizacji i sposób jego wytwarzania, kompozycja farmaceutyczna i sposób jej wytwarzania |
| DE60016191T2 (de) * | 1999-12-08 | 2005-12-22 | Pharmacia Corp., Chicago | Cyclooxygenase-2 hemmer enthaltende zusammensetzungen mit schnellem wirkungseintritt |
| AU2001251650A1 (en) * | 2000-04-18 | 2001-10-30 | Pharmacia Corporation | Rapid-onset formulation of a selective cyclooxigenase-2 |
| US20080009467A1 (en) * | 2000-05-01 | 2008-01-10 | Accera, Inc. | Combinations of medium chain triglycerides and therapeutic agents for the treatment and prevention of alzheimers disease and other diseases resulting from reduced neuronal metabolism |
| AR035642A1 (es) | 2000-05-26 | 2004-06-23 | Pharmacia Corp | Uso de una composicion de celecoxib para el alivio rapido del dolor |
| NZ526169A (en) | 2000-10-31 | 2005-12-23 | Boehringer Ingelheim Pharma | Oral dosage self-emulsifying formulations of pyranone protease inhibitors |
| HUP0400263A2 (hu) | 2001-06-21 | 2005-03-29 | Pfizer Products Inc. | Koleszteril-észter transzfer protein inhibitort tartalmazó önemulgeáló készítmény |
| US20030073609A1 (en) * | 2001-06-29 | 2003-04-17 | Pinkerton Thomas C. | Enhanced pharmacokinetic profile of intradermally delivered substances |
| WO2004000284A1 (en) | 2002-06-21 | 2003-12-31 | Transform Pharmaceuticals, Inc. | Pharmaceutical compositions with improved dissolution |
| IL164163A0 (en) | 2002-04-09 | 2005-12-18 | Pharmacia Corp | Process for preparing a finely self-emulsifiable pharmaceutical composition |
| US6689382B2 (en) * | 2002-05-15 | 2004-02-10 | Procaps S.A. | Soft shell gelatin capsules containing non-steroidal anti-inflammatories |
| WO2004047752A2 (en) | 2002-11-26 | 2004-06-10 | Transform Pharmaceuticals, Inc. | Pharmaceutical formulations of celcoxib |
| CA2537029C (en) * | 2003-11-26 | 2013-03-12 | Likan Liang | Micellar systems useful for delivery of lipophilic or hydrophobic compounds |
| ZA200808114B (en) | 2006-03-28 | 2009-12-30 | Javelin Pharmaceuticals Inc | Formulations of low dose non-steroidal anti-inflammatory drugs and betacyclodextrin |
| EP1961412A1 (en) | 2006-12-27 | 2008-08-27 | LEK Pharmaceuticals D.D. | Self-microemulsifying drug delivery systems |
| WO2008115572A1 (en) | 2007-03-21 | 2008-09-25 | Theraquest Biosciences, Inc. | Methods and compositions of nsaids |
| US20100233272A1 (en) * | 2007-11-15 | 2010-09-16 | Leah Elizabeth Appel | Dosage forms comprising celecoxib providing both rapid and sustained pain relief |
| WO2010150144A2 (en) | 2009-06-25 | 2010-12-29 | Wockhardt Research Centre | Low dose pharmaceutical compositions of celecoxib |
| EP2311446A1 (en) * | 2009-10-16 | 2011-04-20 | Laboratorios Del. Dr. Esteve, S.A. | Compositions comprising Tramadol and Celecoxib in the treatment of pain |
| EP2340819A1 (en) * | 2009-12-23 | 2011-07-06 | Laboratorios Del. Dr. Esteve, S.A. | Compositions comprising venlafaxine and celecoxib in the treatment of pain |
| WO2012037328A2 (en) * | 2010-09-17 | 2012-03-22 | Maine Natural Health, Inc. | Compositions containing omega-3 oil with an anti-inflammatory agent and uses thereof |
| KR101413846B1 (ko) * | 2012-04-12 | 2014-06-30 | 주식회사 종근당 | ４－［５－（４－메칠페닐）－３－（트리플루오로메칠）피라졸－１－일］벤젠술폰아미드 화합물 함유 액상 조성물 |
| KR101455901B1 (ko) * | 2012-05-04 | 2014-11-03 | 성균관대학교산학협력단 | 세레콕시브 및 폴록사머를 포함하는 공융 혼합물 |
| KR20140100170A (ko) * | 2013-02-05 | 2014-08-14 | 에스케이케미칼주식회사 | 셀레콕시브 경구투여용 조성물 |
| MX349193B (es) | 2013-08-27 | 2017-07-18 | Alparis Sa De Cv | Capsula con contenido liquido con un antiinflamatorio. |
| CA2939562C (en) * | 2014-02-11 | 2023-02-14 | Dr. Reddy's Laboratories Ltd. | Parenteral compositions of celecoxib |
| US20150342893A1 (en) * | 2014-05-29 | 2015-12-03 | Sigmoid Pharma Limited | Celecoxib formulations useful for treating colorectal cancer |
| CN117547528A (zh) * | 2015-05-28 | 2024-02-13 | 瑞迪博士实验室有限公司 | 用于治疗疼痛的塞来昔布口服组合物 |
| US20160346300A1 (en) * | 2015-05-29 | 2016-12-01 | Kiel Laboratories, Inc. | Liquid formulations of celecoxib for oral administration |
-
2016
- 2016-05-27 CN CN202311387716.7A patent/CN117547528A/zh active Pending
- 2016-05-27 NZ NZ737561A patent/NZ737561A/en not_active IP Right Cessation
- 2016-05-27 RU RU2017144574A patent/RU2708254C2/ru active
- 2016-05-27 CN CN202111630363.XA patent/CN114209707A/zh active Pending
- 2016-05-27 CA CA2987272A patent/CA2987272C/en active Active
- 2016-05-27 AU AU2016267685A patent/AU2016267685A1/en not_active Abandoned
- 2016-05-27 US US15/167,922 patent/US9572819B2/en active Active
- 2016-05-27 MX MX2017015238A patent/MX384044B/es unknown
- 2016-05-27 JP JP2017561947A patent/JP6605047B2/ja active Active
- 2016-05-27 KR KR1020177035928A patent/KR101994129B1/ko active Active
- 2016-05-27 WO PCT/US2016/034844 patent/WO2016191744A1/en not_active Ceased
- 2016-05-27 CN CN201680031177.5A patent/CN107847437B/zh active Active
- 2016-05-27 EP EP16730581.2A patent/EP3302429A1/en active Pending
- 2016-05-27 EA EA201792530A patent/EA038013B1/ru unknown
- 2016-12-09 US US15/374,951 patent/US9795620B2/en active Active
-
2017
- 2017-09-22 US US15/712,415 patent/US9949990B2/en active Active - Reinstated
-
2018
- 2018-03-15 US US15/922,170 patent/US10376527B2/en active Active
- 2018-03-15 US US15/922,353 patent/US10799517B2/en active Active
-
2019
- 2019-03-29 US US16/369,981 patent/US20190224219A1/en not_active Abandoned
- 2019-05-31 AU AU2019203815A patent/AU2019203815A1/en not_active Abandoned
-
2021
- 2021-09-10 US US17/471,858 patent/US20220241298A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018516266A5 (enExample) | ||
| RU2720204C1 (ru) | Сублингвальная фармацевтическая композиция эдаравона и (+)-2-борнеола | |
| JP7602324B2 (ja) | 重水素化ドンペリドン組成物、方法、及び調製 | |
| BRPI0608853B1 (pt) | composições farmacêuticas e processo para a fabricação de microgrânulos de rifaximina gastrorresistentes | |
| ES2364538T3 (es) | Combinación farmacéutica de alisquireno y valsartán. | |
| JP2011500552A (ja) | 胃腸障害を処置するための医薬用組み合わせおよび組成物 | |
| JP2018513171A (ja) | Ｌ−オルニチンフェニルアセテート製剤 | |
| ES3036967T3 (en) | Delayed release deferiprone tablets and methods of using the same | |
| JP6605047B2 (ja) | 疼痛治療のためのセレコキシブの経口用組成物 | |
| TW201501730A (zh) | 用於口服投藥之包含非晶型托伐普坦（Ｔｏｌｖａｐｔａｎ）的懸浮液 | |
| CN108348475A (zh) | 处于液体剂型的多层药学活性化合物释放微粒 | |
| BR112020026266A2 (pt) | Formulações de 5-hidroxitriptofano (5-htp) para melhor biodisponibilidade para várias indicações | |
| WO2017093444A1 (en) | Compositions for oral administration in the treatment of inflammatory bowel disease | |
| TWI327913B (en) | Pharmaceutical composition comprising 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid | |
| TW201739455A (zh) | 菸鹼醯胺的口服醫藥組成物 | |
| BR112014013374B1 (pt) | Comprimidos de acamprosato e usos de acamprosato referência cruzada aos pedidos relacionados | |
| JP7636489B2 (ja) | ロキソプロフェン又はその塩及びビタミンｂ１２類を含有する経口用医薬組成物 | |
| JPWO2002066030A1 (ja) | ジクロフェナクとオルノプロスチルからなる医薬組成物 | |
| KR101383430B1 (ko) | 새로운 조합의 구강내 속붕해 필름형성 조성물 및 ｐｄｅ５ 저해제가 함유된 구강내 속붕해 필름제제 | |
| AU2022383315B2 (en) | Solid dispersion, preparation method therefor, and solid formulation containing same | |
| WO2010087358A1 (ja) | 新規組成物 | |
| TR201801650T1 (tr) | Kontrollü salim propi̇veri̇n formülasyonlari | |
| RU2483715C2 (ru) | Твердая лекарственная форма препаратов мемантина и его солей | |
| US10471005B2 (en) | Low dose pharmaceutical composition | |
| WO2013157584A1 (ja) | カプセル剤 |